W.O.M. WORLD OF MEDICINE AG
W.O.M. World of Medicine english
WORLD OF MEDICINE outperforms its last targetted yearly goals for 2002
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
A strong fourth quarter leads to an overall increase in revenue for the entire
year/
Thirty-one U100 lasers placed in the field in the fourth quarter/
(Berlin, January 15, 2003)
W.O.M. WORLD OF MEDICINE AG exceeded its sales forecast for the year 2002, which
had resulted after the company’s nine-month figures became available. According
to preliminary figures, revenue increased by approximately 3% to Euro 31
million (previous year: Euro 30.4 million). According to a company statement,
this satisfactory development was not expected after the decline in sales of the
third quarter. Demand clearly increased, however, during end-of-year business,
after the company’s participation at the medical trade show Medica.
In the fourth quarter, WORLD OF MEDICINE was able to post an increase in sales
of approximately 2%, in comparison to the prior year. Thirty-one U100 lasers for
stone fragmentation were placed in the field. Altogether, WORLD OF MEDICINE was
able to place 58 devices with the new FREDDY technology in the market in 2002,
in a very difficult market environment for this branch. This figure includes
direct sales, leasing agreements, and contracts for billing per treatment, and
proves the success of the company’s new, flexible marketing concept. The
development of sales in Asia confirmed the positive tendencies of the previous
quarters, and led to an increase of more than 60% in 2002. Thanks to a push in
the fourth quarter, slight growth was also obtained in the USA.
WORLD OF MEDICINE and its technology are considered to be paving the way for
innovative procedures in the area of Minimally Invasive Surgery – MIS for short-
– with more than 25 years of experience in this growing market. This is
substantiated by the 50 % global market share WORLD OF MEDICINE holds in its
core business Flow&FluidWORLD, long standing relationships with more than 200
business partners, 28 FDA-approved products in the United States, 34 patents,
and the high quality offered by our production facility in Ludwigsstadt/Germany.
The stock of WORLD OF MEDICINE (ISIN DE 0006637390) is listed at the Prime
Standard of the Frankfurt stock exchange.
Stefanie Gehrke (IR/PR), stefanie.gehrke@womcorp.com, Phone: +49 (0) 30 399 81
566
end of ad-hoc-announcement (c)DGAP 15.01.2003
——————————————————————————–
WKN: 663739; ISIN: DE0006637390; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München, Stuttgart
150814 Jän 03
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden